Company
Torax Medical
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2
510(k), De Novo and PMA
Device trials
8
As lead sponsor, any status
Adverse event reports
143
Received Nov 1, 2025 to Nov 20, 2026
Recall records
5
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$77.0M
6 Form D offerings, 2009 to 2016
Equity
$70.0M
Stock sold for cash
Debt and convertible notes
$7.0M
$7.0M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $25.0M raised of $25.0M sought, first sale Jul 15, 2016, 17 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jul 15, 2016 | Equity | $25.0M | $25.0M | 17 | Rule 506(b) | Form D ↗Jul 25, 2016 |
5 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- TORAX MEDICAL INC
- Headquarters
- Shoreview, Minnesota
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1214172 ↗
Executives, directors and promoters
As listed on the latest Form D.
6 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
No 5%+ shareholder filings, SBIR grants or venture investors found under the name Torax Medical.
Latest FDA decisions
K230089 · Decided Feb 9, 2023 · 28 days after receipt
Device type: Laparoscopic Accessories, Esophageal Sizing (QJN) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT01940185 · 200 participants · Start Jun 30, 2012 · Primary completion Jun 30, 2023
Device: LINX device · For: Gastroesophageal Reflux Disease (GERD)
Sites: Los Angeles, California; San Diego, California; Englewood, Colorado · 19 sites in all
7 more trials with a free account
Reports received
143
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
5
3.5% of reports
Injury reports
138
97% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 26 | 0 | 0 |
| Jan 24 | 0 | 22 | 0 | 0 |
| Feb 24 | 0 | 15 | 0 | 0 |
| Mar 24 | 1 | 11 | 0 | 0 |
| Apr 24 | 2 | 24 | 0 | 0 |
| May 24 | 0 | 9 | 0 | 0 |
| Jun 24 | 0 | 8 | 0 | 0 |
| Jul 24 | 0 | 15 | 0 | 0 |
| Aug 24 | 1 | 10 | 0 | 0 |
| Sep 24 | 0 | 10 | 0 | 0 |
| Oct 24 | 0 | 15 | 0 | 0 |
| Nov 24 | 0 | 12 | 0 | 0 |
| Dec 24 | 2 | 11 | 0 | 0 |
| Jan 25 | 1 | 6 | 0 | 0 |
| Feb 25 | 1 | 11 | 0 | 0 |
| Mar 25 | 1 | 16 | 0 | 0 |
| Apr 25 | 0 | 16 | 0 | 0 |
| May 25 | 0 | 13 | 0 | 0 |
| Jun 25 | 2 | 13 | 0 | 0 |
| Jul 25 | 1 | 10 | 0 | 0 |
| Aug 25 | 0 | 33 | 0 | 0 |
| Sep 25 | 0 | 5 | 0 | 0 |
| Oct 25 | 0 | 16 | 0 | 0 |
| Nov 25 | 0 | 11 | 0 | 0 |
| Dec 25 | 0 | 8 | 0 | 0 |
| Jan 26 | 0 | 16 | 0 | 0 |
| Feb 26 | 1 | 14 | 0 | 0 |
| Mar 26 | 0 | 15 | 0 | 0 |
| Apr 26 | 1 | 6 | 0 | 0 |
| May 26 | 0 | 16 | 0 | 0 |
| Jun 26 | 1 | 9 | 0 | 0 |
| Jul 26 | 0 | 11 | 0 | 0 |
| Aug 26 | 0 | 7 | 0 | 0 |
| Sep 26 | 0 | 12 | 0 | 0 |
| Oct 26 | 2 | 13 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- LINX85
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2037-2018 · Started Apr 20, 2018
Reason given: Possible out of specification condition which may allow a bead component to separate from an adjacent wire link. This condition may result in a discontinuous or open LINX device.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Implant, Anti-Gastroesophageal Reflux (LEI)
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.